Sfoglia per Autore
New 1,5-diphenyl pyrrole derivatives as anti-inflammatory COX-2 selective compounds and their use as potential antitumoral agents.
2012 Consalvi, Sara; Battilocchio, Claudio; Poce, Giovanna; Alfonso, Salvatore; Porretta, Giulio Cesare; M., Anzini; L., Sautebin; C., Ghelardini; A., Giordani; P., Patrignani; V., Calderone; Biava, Mariangela
New Pyrrole Derivatives as Anti-inflammatory and Analgesic Agents: Design, Synthesis and Biological Evaluation
2012 Biava, Mariangela; Consalvi, Sara; Poce, Giovanna; Battilocchio, Claudio; Alfonso, Salvatore; Ghelardini, C.; Sautebin, L.
Improving the solubility of a new class of antiinflammatory pharmacodynamic hybrids, that release nitric oxide and inhibit cycloxygenase-2 isoenzyme
2012 Biava, Mariangela; Battilocchio, Claudio; Poce, Giovanna; Alfonso, Salvatore; Porretta, Giulio Cesare; Consalvi, Sara; Vincenzo, Calderone; Alma, Martelli; Lara, Testai; Carla, Ghelardini; Lorenzo Di Cesare, Mannelli; Lidia, Sautebin; Antonietta, Rossi; Antonio, Giordani; Paola, Patrignani; Maurizio, Anzini
A class of pyrrole derivatives endowed with analgesic/anti-inflammatory activity
2013 Battilocchio, Claudio; Poce, Giovanna; Alfonso, Salvatore; Porretta, Giulio Cesare; Consalvi, Sara; L., Sautebin; S., Pace; A., Rossi; C., Ghelardini; L., Di Cesare Mannelli; S., Schenone; A., Giordani; L., Di Francesco; P., Patrignani; Biava, Mariangela
The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunction
2013 Martelli, A; Testai, L; Anzini, M; Cappelli, A; Di Capua, A; Biava, Mariangela; Poce, Giovanna; Consalvi, Sara; Giordani, A; Caselli, G; Rovati, L; Ghelardini, C; Patrignani, P; Sautebin, L; Breschi, Mc; Calderone, V.
Improving the solubility and the biological profile of a novel class of derivatives as selective COX-2 inhibiting nitric oxide donors
2013 Consalvi, Sara; G., Poce; Alfonso, Salvatore; Battilocchio, Claudio; G. C., Porretta; V., Calderone; A., Martelli; L., Testai; L., Sautebin; A., Rossi; C., Ghelardini; L., Di Cesare Mannelli; A., Giordani; P., Patrignani; M., Anzini; Biava, Mariangela
Development of a novel class of derivatives as selective COX-2 inhibiting Nitric Oxide donors: improving the solubility and the biological profile
2013 Consalvi, Sara; G., Poce; Battilocchio, Claudio; Alfonso, Salvatore; V., Calderone; A., Martelli; L., Testai; L., Sautebin; A., Rossi; C., Ghelardini; L., Di Cesare Mannelli; A., Giordani; P., Patrignani; M., Anzini; M., Biava
Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors
2014 Biava, Mariangela; Battilocchio, Claudio; Poce, Giovanna; Alfonso, Salvatore; Consalvi, Sara; Angela Di, Capua; Vincenzo, Calderone; Alma, Martelli; Lara, Testai; Lidia, Sautebin; Antonietta, Rossi; Carla, Ghelardini; Lorenzo Di Cesare, Mannelli; Antonio, Giordani; Stefano, Persiani; Milena, Colovic; Melania, Dovizio; Paola, Patrignani; Maurizio, Anzini
SAR analysis of new anti-TB drugs currently in pre-clinical and clinical development
2014 Poce, Giovanna; Cocozza, Martina; Consalvi, Sara; Biava, Mariangela
Synthesis, biological evaluation and docking analysis of a new series of methylsulfonyl and sulfamoyl acetamides and ethyl acetates as potent COX-2 inhibitors
2015 Consalvi, Sara; Alfonso, Salvatore; Di Capua, Angela; Poce, Giovanna; Pirolli, Adele; Sabatino, Manuela; Ragno, Rino; Anzini, Maurizio; Sartini, Stefania; La Motta, Concettina; Di Cesare Mannelli, Lorenzo; Ghelardini, Carla; Biava, Mariangela
COX inhibitors: a patent review (2011 - 2014)
2015 Consalvi, Sara; Biava, Mariangela; Poce, Giovanna
MmpL3 inhibitors: diverse chemical scaffolds inhibit the same target
2016 Poce, Giovanna; Consalvi, Sara; Biava, Mariangela
A series of COX-2 inhibitors endowed with NO-releasing properties: synthesis, biological evaluation, and docking analysis
2016 Consalvi, Sara; Poce, Giovanna; Ragno, Rino; Sabatino, Manuela; Lamotta, Concettina; Sartini, Stefania; Calderone, Vincenzo; Martelli, Alma; Ghelardini, Carla; Dicesaremannelli, Lorenzo; Biava, Mariangela
Novel inhibitors of Mycobacterium tuberculosis tryptophan biosynthetic pathway to treat tuberculosis
2016 Venditti, Giulia; Consalvi, Sara; Helena, Boshoff; Biava, Mariangela; Poce, Giovanna
1,5-Diarylpyrroles as potent antitubercular and anti-inflammatory agents
2017 Venditti, Giulia; Poce, Giovanna; Consalvi, Sara; Biava, Mariangela
Pharmaceutical salt of BM635 with improved bioavailability
2017 Poce, Giovanna; Consalvi, Sara; Cocozza, Martina; Fernandez Menendez, Raquel; Bates, Robert H.; Ortega Muro, Fátima; Barros Aguirre, David; Ballell, Lluis; Biava, Mariangela
In vivo potent BM635 analogue with improved drug-like properties
2018 Poce, Giovanna; Cocozza, Martina; Alfonso, Salvatore; Consalvi, Sara; Venditti, Giulia; Fernandez-Menendez, Raquel; Bates, Robert H.; Barros Aguirre, David; Ballell, Lluis; De Logu, Alessandro; Vistoli, Giulio; Biava, Mariangela
Novel pyrazole-containing compounds active against mycobacterium tuberculosis
2019 Poce, Giovanna; Consalvi, Sara; Venditti, Giulia; Alfonso, Salvatore; Desideri, Nicoletta; Fernandez-Menendez, Raquel; Bates, Robert H.; Ballell, Lluis; Barros Aguirre, David; Rullas, Joaquin; De Logu, Alessandro; Gardner, Michelle; Ioerger, Thomas R.; Rubin, Eric J.; Biava, Mariangela
Chocolate consumers and lymphocyte-to-monocyte ratio: a working hypothesis from a preliminary report of a pilot study in celiac subjects
2019 Raguzzini, A; Poce, G; Consalvi, S; Toti, E; Palmacci, F; Biava, M; Peluso, I
Mycobacterial tryptophan biosynthesis: a promising target for tuberculosis drug development?
2019 Consalvi, Sara; Scarpecci, Cristina; Biava, Mariangela; Poce, Giovanna
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| New 1,5-diphenyl pyrrole derivatives as anti-inflammatory COX-2 selective compounds and their use as potential antitumoral agents. | 2012 | Consalvi, Sara; Battilocchio, Claudio; Poce, Giovanna; Alfonso, Salvatore; Porretta, Giulio Cesare; M., Anzini; L., Sautebin; C., Ghelardini; A., Giordani; P., Patrignani; V., Calderone; Biava, Mariangela | |
| New Pyrrole Derivatives as Anti-inflammatory and Analgesic Agents: Design, Synthesis and Biological Evaluation | 2012 | Biava, Mariangela; Consalvi, Sara; Poce, Giovanna; Battilocchio, Claudio; Alfonso, Salvatore; Ghelardini, C.; Sautebin, L. | |
| Improving the solubility of a new class of antiinflammatory pharmacodynamic hybrids, that release nitric oxide and inhibit cycloxygenase-2 isoenzyme | 2012 | Biava, Mariangela; Battilocchio, Claudio; Poce, Giovanna; Alfonso, Salvatore; Porretta, Giulio Cesare; Consalvi, Sara; Vincenzo, Calderone; Alma, Martelli; Lara, Testai; Carla, Ghelardini; Lorenzo Di Cesare, Mannelli; Lidia, Sautebin; Antonietta, Rossi; Antonio, Giordani; Paola, Patrignani; Maurizio, Anzini | |
| A class of pyrrole derivatives endowed with analgesic/anti-inflammatory activity | 2013 | Battilocchio, Claudio; Poce, Giovanna; Alfonso, Salvatore; Porretta, Giulio Cesare; Consalvi, Sara; L., Sautebin; S., Pace; A., Rossi; C., Ghelardini; L., Di Cesare Mannelli; S., Schenone; A., Giordani; L., Di Francesco; P., Patrignani; Biava, Mariangela | |
| The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunction | 2013 | Martelli, A; Testai, L; Anzini, M; Cappelli, A; Di Capua, A; Biava, Mariangela; Poce, Giovanna; Consalvi, Sara; Giordani, A; Caselli, G; Rovati, L; Ghelardini, C; Patrignani, P; Sautebin, L; Breschi, Mc; Calderone, V. | |
| Improving the solubility and the biological profile of a novel class of derivatives as selective COX-2 inhibiting nitric oxide donors | 2013 | Consalvi, Sara; G., Poce; Alfonso, Salvatore; Battilocchio, Claudio; G. C., Porretta; V., Calderone; A., Martelli; L., Testai; L., Sautebin; A., Rossi; C., Ghelardini; L., Di Cesare Mannelli; A., Giordani; P., Patrignani; M., Anzini; Biava, Mariangela | |
| Development of a novel class of derivatives as selective COX-2 inhibiting Nitric Oxide donors: improving the solubility and the biological profile | 2013 | Consalvi, Sara; G., Poce; Battilocchio, Claudio; Alfonso, Salvatore; V., Calderone; A., Martelli; L., Testai; L., Sautebin; A., Rossi; C., Ghelardini; L., Di Cesare Mannelli; A., Giordani; P., Patrignani; M., Anzini; M., Biava | |
| Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors | 2014 | Biava, Mariangela; Battilocchio, Claudio; Poce, Giovanna; Alfonso, Salvatore; Consalvi, Sara; Angela Di, Capua; Vincenzo, Calderone; Alma, Martelli; Lara, Testai; Lidia, Sautebin; Antonietta, Rossi; Carla, Ghelardini; Lorenzo Di Cesare, Mannelli; Antonio, Giordani; Stefano, Persiani; Milena, Colovic; Melania, Dovizio; Paola, Patrignani; Maurizio, Anzini | |
| SAR analysis of new anti-TB drugs currently in pre-clinical and clinical development | 2014 | Poce, Giovanna; Cocozza, Martina; Consalvi, Sara; Biava, Mariangela | |
| Synthesis, biological evaluation and docking analysis of a new series of methylsulfonyl and sulfamoyl acetamides and ethyl acetates as potent COX-2 inhibitors | 2015 | Consalvi, Sara; Alfonso, Salvatore; Di Capua, Angela; Poce, Giovanna; Pirolli, Adele; Sabatino, Manuela; Ragno, Rino; Anzini, Maurizio; Sartini, Stefania; La Motta, Concettina; Di Cesare Mannelli, Lorenzo; Ghelardini, Carla; Biava, Mariangela | |
| COX inhibitors: a patent review (2011 - 2014) | 2015 | Consalvi, Sara; Biava, Mariangela; Poce, Giovanna | |
| MmpL3 inhibitors: diverse chemical scaffolds inhibit the same target | 2016 | Poce, Giovanna; Consalvi, Sara; Biava, Mariangela | |
| A series of COX-2 inhibitors endowed with NO-releasing properties: synthesis, biological evaluation, and docking analysis | 2016 | Consalvi, Sara; Poce, Giovanna; Ragno, Rino; Sabatino, Manuela; Lamotta, Concettina; Sartini, Stefania; Calderone, Vincenzo; Martelli, Alma; Ghelardini, Carla; Dicesaremannelli, Lorenzo; Biava, Mariangela | |
| Novel inhibitors of Mycobacterium tuberculosis tryptophan biosynthetic pathway to treat tuberculosis | 2016 | Venditti, Giulia; Consalvi, Sara; Helena, Boshoff; Biava, Mariangela; Poce, Giovanna | |
| 1,5-Diarylpyrroles as potent antitubercular and anti-inflammatory agents | 2017 | Venditti, Giulia; Poce, Giovanna; Consalvi, Sara; Biava, Mariangela | |
| Pharmaceutical salt of BM635 with improved bioavailability | 2017 | Poce, Giovanna; Consalvi, Sara; Cocozza, Martina; Fernandez Menendez, Raquel; Bates, Robert H.; Ortega Muro, Fátima; Barros Aguirre, David; Ballell, Lluis; Biava, Mariangela | |
| In vivo potent BM635 analogue with improved drug-like properties | 2018 | Poce, Giovanna; Cocozza, Martina; Alfonso, Salvatore; Consalvi, Sara; Venditti, Giulia; Fernandez-Menendez, Raquel; Bates, Robert H.; Barros Aguirre, David; Ballell, Lluis; De Logu, Alessandro; Vistoli, Giulio; Biava, Mariangela | |
| Novel pyrazole-containing compounds active against mycobacterium tuberculosis | 2019 | Poce, Giovanna; Consalvi, Sara; Venditti, Giulia; Alfonso, Salvatore; Desideri, Nicoletta; Fernandez-Menendez, Raquel; Bates, Robert H.; Ballell, Lluis; Barros Aguirre, David; Rullas, Joaquin; De Logu, Alessandro; Gardner, Michelle; Ioerger, Thomas R.; Rubin, Eric J.; Biava, Mariangela | |
| Chocolate consumers and lymphocyte-to-monocyte ratio: a working hypothesis from a preliminary report of a pilot study in celiac subjects | 2019 | Raguzzini, A; Poce, G; Consalvi, S; Toti, E; Palmacci, F; Biava, M; Peluso, I | |
| Mycobacterial tryptophan biosynthesis: a promising target for tuberculosis drug development? | 2019 | Consalvi, Sara; Scarpecci, Cristina; Biava, Mariangela; Poce, Giovanna |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile